Hermes

Exclusive Content

Essential Healthcare Compliance Resources for Foreign Medical Firms in China

CG360 Healthcare Resource 051 - Essential Healthcare Compliance Resources for Foreign Medical Firms in China * { margin: 0; padding: 0; box-sizing: bo

Essential Clinical Trial Resources for Foreign Healthcare Companies in China

Essential Clinical Trial Resources for Foreign Healthcare Companies in China Essential Clinical Trial Resources for Foreign Healthcare Companies in Ch

Essential Drug Approval Resources for Foreign Pharma Companies in China

CG360-HEALTHCARE-RESO-049 — Essential Drug Approval Resources for Foreign Pharma Companies in China body { font-family: 'Segoe UI', Roboto, Helvetica,

Essential NMPA Medical Device Registration Resources for Foreign Companies in China

Essential NMPA Medical Device Registration Resources for Foreign Companies in China body { font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-seri

Healthcare in China Update: Medical Device Unique Device Identification (UDI) Mandate — Key Takeaways

```html Healthcare in China Update: Medical Device UDI Mandate — Key Takeaways body { font-family: 'Segoe UI', Arial, sans-serif; line-height: 1.6; co

Healthcare in China Update: New Medical AI Software Classification Rules — Key Takeaways

Here is a news article analyzing China’s updated medical AI software classification rules, structured for foreign executives evaluating regulatory ris